🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Muscular Synergies and Behavioral Adaptations of Gait in Pain Anticipation (SYAMAPP)

RecruitingNAAges 18 Years - 35 YearsAllUniversite de Picardie Jules Verne
NCT06929559 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to determine whether the anticipation of pain influences gait control and psychophysiological responses in healthy individuals. Participants will receive a neutral cream described either as potentially painful (experimental group) or inert (control group), and their behavioral and physiological adaptations will be measured during walking tasks.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Aged 18-35 years * Healthy participant with no self-reported diagnosed neurological, musculoskeletal, or cardiovascular disorders * Body Mass Index (BMI) \< 30 * Ability to walk unaided for at least 10 minutes without major physical limitations Exclusion Criteria: * Presence of pain at the time of testing * Self-reported diagnosed condition affecting mobility * Known allergy to any component of the study cream * Allergy to EMG electrode adhesives * Inability to stand unassisted for more than 1 minute * Inability to walk/run at the required speed and distance * Weight exceeding 150 kg (due to treadmill limitations) * Recent intake of: * Analgesics (within 6 hours) * Cigarettes (within 6 hours) * Caffeine (within 2 hours) * Skin lesions at the cream application site * Pregnancy * Failure to understand instructions * Daytime pain reported by participant on day of experimentation
💊

What it tests

  • Pain expectation conditioning
  • Comparator (Control Group)
  • Intervention: Gait
📍

Where

1 site
Université de Picardie Jules Verne
Amiens, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy